DFTX
Definium Therapeutics Inc
NASDAQ · Pharmaceuticals
$16.90
+0.65 (+4.00%)
Open$16.49
Previous Close$16.25
Day High$17.02
Day Low$16.46
52W High$18.70
52W Low$14.62
Volume—
Avg Volume1.90M
Market Cap1.66B
P/E Ratio—
EPS$-1.97
SectorPharmaceuticals
Analyst Ratings
Strong Buy
19 analysts
Price Target
+172.2% upside
Current
$16.90
$16.90
Target
$46.00
$46.00
$39.37
$46.00 avg
$57.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 685.27M | 628.04M | 535.94M |
| Net Income | 136.42M | 119.21M | 84.03M |
| Profit Margin | 19.9% | 19.0% | 15.7% |
| EBITDA | 222.00M | 198.31M | 161.40M |
| Free Cash Flow | 100.39M | 95.21M | 82.42M |
| Rev Growth | -7.8% | +7.1% | -9.9% |
| Debt/Equity | 0.71 | 0.57 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |